Karttunen P, Saano V, Paronen P, Peura P, Vidgren M
Medfiles Ltd., Kuopio, Finland.
Int J Clin Pharmacol Ther Toxicol. 1990 Jun;28(6):251-5.
The pharmacokinetic properties of two 200 mg, over-the-counter (OTC) ibuprofen preparations were compared in a randomized crossover study on ten healthy volunteers. After 2 times 200 mg single dose, one preparation produced peak plasma ibuprofen concentration 30.0 +/- 2.1 micrograms/ml at 1.6 h and the other preparation 23.2 +/- 1.9 micrograms/ml at 2.3 h (p less than 0.05). There was no statistically significant difference between the preparations in the bioavailability of ibuprofen. OTC ibuprofen preparations are mainly used for acute indications, such as fever or headache. In these cases, rapid absorption and high concentrations of active ingredient are desirable properties, especially when the amount of drug is relatively low. Therefore, the pharmacokinetic differences between these preparations may be therapeutically significant.
在一项针对10名健康志愿者的随机交叉研究中,对两种200毫克的非处方布洛芬制剂的药代动力学特性进行了比较。在两次服用200毫克单剂量后,一种制剂在1.6小时时产生的血浆布洛芬峰值浓度为30.0±2.1微克/毫升,另一种制剂在2.3小时时为23.2±1.9微克/毫升(p<0.05)。两种制剂在布洛芬的生物利用度方面没有统计学上的显著差异。非处方布洛芬制剂主要用于急性病症,如发烧或头痛。在这些情况下,快速吸收和高浓度的活性成分是理想的特性,尤其是当药物剂量相对较低时。因此,这些制剂之间的药代动力学差异可能具有治疗意义。